BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 889518)

  • 1. Swimmer's goggles for keratoconjunctivitis sicca.
    Poirier RH; Ryburn FM; Israel CW
    Arch Ophthalmol; 1977 Aug; 95(8):1405-6. PubMed ID: 889518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren syndrome.
    Marsh P; Pflugfelder SC
    Ophthalmology; 1999 Apr; 106(4):811-6. PubMed ID: 10201607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca.
    Fox RI; Chan R; Michelson JB; Belmont JB; Michelson PE
    Arthritis Rheum; 1984 Apr; 27(4):459-61. PubMed ID: 6712760
    [No Abstract]   [Full Text] [Related]  

  • 4. Tear function parameters in keratoconjunctivitis sicca with and without the association of Sjögren's syndrome.
    Mackor AJ; van Bijsterveld OP
    Ophthalmologica; 1988; 196(4):169-74. PubMed ID: 3173983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of the dry eye in Sjogren's syndrome.
    Williamson J; Doig WM; Forrester JV; Tham MH; Wilson T; Whaley K; Dick WC
    Br J Ophthalmol; 1974 Sep; 58(9):798-805. PubMed ID: 4433493
    [No Abstract]   [Full Text] [Related]  

  • 6. [Oxidative stress correction in the treatment of severe keratoconjunctivitis sicca in patients with Sjorgen's syndrome].
    Safonova TN; Gladkova OV; Boev VI
    Vestn Oftalmol; 2019; 135(1):59-66. PubMed ID: 30830076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics of keratoconjunctivitis sicca in Sjögren's disease and syndrome].
    Safonova TN; Iudina IuV
    Ter Arkh; 1988; 60(4):30-1. PubMed ID: 3394092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lacrimal punctum occlusion in the treatment of severe keratoconjunctivitis Sicca caused by Sjögren syndrome: a uniocular evaluation.
    Mansour K; Leonhardt CJ; Kalk WW; Bootsma H; Bruin KJ; Blanksma LJ;
    Cornea; 2007 Feb; 26(2):147-50. PubMed ID: 17251802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current treatments of xerophthalmia in Sjögren's syndrome].
    Baudouin C; Pisella PJ; Brignole F
    Rev Med Interne; 2004 May; 25(5):376-82. PubMed ID: 15110955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keratoconjunctivitis sicca in rheumatoid arthritis.
    Drosos AA; Andonopoulos AP; Skopouli FN
    Clin Rheumatol; 1988 Dec; 7(4):547-8. PubMed ID: 3246141
    [No Abstract]   [Full Text] [Related]  

  • 11. Sjogren's syndrome. I. Sicca components.
    Whaley K; Williamson J; Chisholm DM; Webb J; Mason DK; Buchanan WW
    Q J Med; 1973 Apr; 42(166):279-304. PubMed ID: 4785436
    [No Abstract]   [Full Text] [Related]  

  • 12. Ocular manifestations of Sjögren's syndrome: keratoconjunctivitis sicca.
    Friedlaender MH
    Rheum Dis Clin North Am; 1992 Aug; 18(3):591-608. PubMed ID: 1496163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Precorneal film and its significance in the therapy of "dry eye"].
    Jaeger W
    Buch Augenarzt; 1981; (84):40-53. PubMed ID: 7284872
    [No Abstract]   [Full Text] [Related]  

  • 14. Ophthalmological tests in patients with keratoconjunctivitis sicca with and without association of primary Sjögren's syndrome.
    Rivas L; Alvarez MI; Rodriguez JJ; Murube J
    Ger J Ophthalmol; 1995 Sep; 4(5):306-10. PubMed ID: 7496343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus (types 1 and 2) in the tear film in Sjogren's syndrome and HIV infection.
    Willoughby CE; Baker K; Kaye SB; Carey P; O'Donnell N; Field A; Longman L; Bucknall R; Hart CA
    J Med Virol; 2002 Nov; 68(3):378-83. PubMed ID: 12226825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Beneficial effect of the local application of plasma fibronectin and autologous serum in patients with the keratoconjunctivitis sicca of Sjögren's syndrome].
    Kono I; Kono K; Narushima K; Akama T; Suzuki H; Yamane K; Kashiwagi H
    Ryumachi; 1986 Oct; 26(5):339-43. PubMed ID: 3603237
    [No Abstract]   [Full Text] [Related]  

  • 17. Recurrence after topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren's syndrome.
    Hong S; Kim T; Chung SH; Kim EK; Seo KY
    J Ocul Pharmacol Ther; 2007 Feb; 23(1):78-82. PubMed ID: 17341155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effect of topical fibronectin in patients with keratoconjunctivitis sicca of Sjögren's syndrome.
    Kono I; Matsumoto Y; Kono K; Ishibashi Y; Narushima K; Kabashima T; Yamane K; Sakurai T; Kashiwagi H
    J Rheumatol; 1985 Jun; 12(3):487-9. PubMed ID: 4045849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of Gougerot-Sjögren's disease. Therapeutic note apropos of 2 cases].
    Charleux J
    Bull Soc Ophtalmol Fr; 1967 Feb; 67(2):339-41. PubMed ID: 5612445
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation and differential diagnosis of keratoconjunctivitis sicca.
    Lemp MA
    J Rheumatol Suppl; 2000 Dec; 61():11-4. PubMed ID: 11128698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.